12 Month Price Forecast For DHI
Distance to DHI Price Forecasts
DHI Price Momentum
๐ค Considering D.R. Horton (DHI)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 6:26 AM UTC
DHI Analyst Ratings & Price Targets
Based on our analysis of 33 Wall Street analysts, DHI has a neutral consensus with a median price target of $168.00 (ranging from $125.00 to $220.00). The overall analyst rating is Buy (7.1/10). Currently trading at $130.21, the median forecast implies a 29.0% upside. This outlook is supported by 8 Buy, 12 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Sam Reid at Wells Fargo, projecting a 69.0% upside. Conversely, the most conservative target is provided by Mike Dahl at RBC Capital, suggesting a 4.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DHI Analyst Consensus
DHI Price Target Range
Latest DHI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DHI.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jan 22, 2025 | Barclays | Matthew Bouley | Equal-Weight | Maintains | $145.00 |
Jan 22, 2025 | JMP Securities | Aaron Hecht | Market Outperform | Reiterates | $210.00 |
Jan 22, 2025 | RBC Capital | Mike Dahl | Underperform | Reiterates | $125.00 |
Jan 16, 2025 | Barclays | Matthew Bouley | Equal-Weight | Maintains | $150.00 |
Jan 14, 2025 | Goldman Sachs | Susan Maklari | Buy | Maintains | $171.00 |
Jan 8, 2025 | UBS | John Lovallo | Buy | Maintains | $203.00 |
Jan 6, 2025 | Citigroup | Anthony Pettinari | Neutral | Maintains | $152.00 |
Dec 17, 2024 | Wells Fargo | Sam Reid | Overweight | Maintains | $175.00 |
Dec 13, 2024 | JP Morgan | Michael Rehaut | Underweight | Downgrade | $156.00 |
Dec 11, 2024 | Barclays | Matthew Bouley | Equal-Weight | Downgrade | $170.00 |
Nov 7, 2024 | Raymond James | Buck Horne | Market Perform | Downgrade | $0.00 |
Nov 4, 2024 | JP Morgan | Michael Rehaut | Neutral | Maintains | $188.00 |
Oct 31, 2024 | Barclays | Matthew Bouley | Overweight | Maintains | $192.00 |
Oct 30, 2024 | BTIG | Carl Reichardt | Buy | Maintains | $186.00 |
Oct 30, 2024 | Evercore ISI Group | Stephen Kim | Outperform | Maintains | $204.00 |
Oct 30, 2024 | Wells Fargo | Sam Reid | Overweight | Maintains | $190.00 |
Oct 30, 2024 | Citigroup | Anthony Pettinari | Neutral | Maintains | $185.00 |
Oct 30, 2024 | RBC Capital | Mike Dahl | Underperform | Maintains | $145.00 |
Oct 30, 2024 | UBS | John Lovallo | Buy | Maintains | $214.00 |
Sep 19, 2024 | B of A Securities | Rafe Jadrosich | Buy | Maintains | $215.00 |
Stocks Similar to DR Horton Inc
The following stocks are similar to D.R. Horton based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

DR Horton Inc (DHI) Financial Data
DR Horton Inc has a market capitalization of $41.89B with a P/E ratio of 9.2x. The company generates $36.80B in trailing twelve-month revenue with a 12.9% profit margin.
Revenue growth is -4.8% quarter-over-quarter, while maintaining an operating margin of +16.6% and return on equity of +19.6%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

DR Horton Inc (DHI) Company Overview
About DR Horton Inc
Homebuilding company operating across the U.S.
The company generates revenue through the acquisition and development of land, construction, and sale of residential homes, including single-family and attached homes. It also provides mortgage financing, title insurance services, and engages in the development of residential lots, contributing to its diversified income streams.
Founded in 1978 and headquartered in Arlington, Texas, the company operates in 125 markets across 36 states. In addition to residential properties, D.R. Horton develops and manages multi-family rental properties and owns non-residential real estate, enhancing its investment portfolio.
Company Information
Sector
Consumer Cyclical
Industry
Residential Construction
Employees
13,450
CEO
Mr. Paul J. Romanowski
Country
United States
IPO Year
1992
Website
www.drhorton.comDR Horton Inc (DHI) Latest News & Analysis
Shares of homebuilders and construction companies fell due to concerns that new tariffs may increase building costs.
Rising building costs from new tariffs can squeeze profit margins for homebuilders and construction firms, likely leading to decreased earnings and investor sentiment in the sector.
3 Stocks Down 20% Over the Past Six Months But Wall Street Thinks Will Pop 20% Or More This Year
8 days agoIn January 2025, most stocks saw a significant decline, with many indices down approximately 20%. Investors should monitor market conditions closely.
A 20% decline in major indices signals heightened market volatility, potential economic issues, and may lead to increased selling pressure and reduced investor confidence.
Increased tariffs on lumber and building materials are raising construction costs, which are expected to be passed on to consumers.
Increased tariffs raise construction costs, potentially leading to higher home prices and reduced demand, impacting real estate investments and related sectors.
Here's Why D.R. Horton Is Looking Attractive
12 days agoD.R. Horton is being viewed as an attractive investment opportunity, suggesting potential positive developments or financial performance that may interest investors.
D.R. Horton's attractiveness signals potential growth in the housing market, suggesting possible gains for investors in real estate and construction sectors.
The Investment Committee is currently discussing the latest investment recommendations, referred to as "Calls of the Day."
The Investment Committee's discussions on Calls of the Day can influence market sentiment and stock prices, impacting investment strategies and portfolio performance.
Homebuilders Brace For Tough 2025, Analyst Downgrades D.R. Horton And Smith Douglas Amid Market Pressures
15 days agoBofA Securities downgraded D.R. Horton, Inc. (DHI) and Smith Douglas Homes Corp. (SDHC) due to a challenging outlook for homebuilder stocks ahead of the spring selling season.
The downgrade signals potential weakness in the homebuilding sector, suggesting lower demand and profitability, which could negatively impact stock performance for D.R. Horton and Smith Douglas.
Frequently Asked Questions About DHI Stock
What is DR Horton Inc's (DHI) stock forecast for 2025?
Based on our analysis of 33 Wall Street analysts, DR Horton Inc (DHI) has a median price target of $168.00. The highest price target is $220.00 and the lowest is $125.00.
Is DHI stock a good investment in 2025?
According to current analyst ratings, DHI has 8 Buy ratings, 12 Hold ratings, and 2 Sell ratings. The stock is currently trading at $130.21. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for DHI stock?
Wall Street analysts predict DHI stock could reach $168.00 in the next 12 months. This represents a 29.0% increase from the current price of $130.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is DR Horton Inc's business model?
The company generates revenue through the acquisition and development of land, construction, and sale of residential homes, including single-family and attached homes. It also provides mortgage financing, title insurance services, and engages in the development of residential lots, contributing to its diversified income streams.
What is the highest forecasted price for DHI DR Horton Inc?
The highest price target for DHI is $220.00 from Sam Reid at Wells Fargo, which represents a 69.0% increase from the current price of $130.21.
What is the lowest forecasted price for DHI DR Horton Inc?
The lowest price target for DHI is $125.00 from Mike Dahl at RBC Capital, which represents a -4.0% decrease from the current price of $130.21.
What is the overall DHI consensus from analysts for DR Horton Inc?
The overall analyst consensus for DHI is neutral. Out of 33 Wall Street analysts, 8 rate it as Buy, 12 as Hold, and 2 as Sell, with a median price target of $168.00.
How accurate are DHI stock price projections?
Stock price projections, including those for DR Horton Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.